Alector (ALEC) Total Non-Current Liabilities (2018 - 2026)

Alector's (ALEC) quarterly Total Non-Current Liabilities came in at $227.8 million in Q1 2026, down 27.07% year-on-year from $312.3 million in Q1 2025, and down 12.68% on a QoQ basis from $260.9 million in Q4 2025.

Alector (ALEC) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of Total Non-Current Liabilities data on file, last reported at $227.8 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 27.07% year-over-year to $227.8 million in Q1 2026; TTM through Mar 2026 was $227.8 million, a 27.07% decrease from a year earlier, with the FY2025 full-year figure at $260.9 million, down 23.34% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $227.8 million, down from $260.9 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for ALEC reached as high as $686.8 million in Q1 2022 and fell as low as $227.8 million in Q1 2026.
  • Historically, Total Non-Current Liabilities has averaged $440.4 million across 5 years, with a median of $455.2 million in 2024.
  • Across the five-year window, Total Non-Current Liabilities soared 223.37% in 2022 and sank 32.25% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $572.4 million in 2022, then retreated by 15.05% to $486.3 million in 2023, then sank by 30.03% to $340.3 million in 2024, then dropped by 23.34% to $260.9 million in 2025, then dropped by 12.68% to $227.8 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $227.8 million in Q1 2026, $260.9 million in Q4 2025, and $276.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Alector 164.78 Mn -41.74 Mn - 227.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 227.76 Mn
Dec 31, 2025 260.85 Mn
Sep 30, 2025 276.13 Mn
Jun 30, 2025 283.80 Mn
Mar 31, 2025 312.30 Mn
Dec 31, 2024 340.27 Mn
Sep 30, 2024 395.86 Mn
Jun 30, 2024 418.93 Mn
Mar 31, 2024 455.21 Mn
Dec 31, 2023 486.30 Mn
Sep 30, 2023 508.94 Mn
Jun 30, 2023 511.53 Mn
Mar 31, 2023 564.43 Mn
Dec 31, 2022 572.45 Mn
Sep 30, 2022 583.70 Mn
Jun 30, 2022 600.92 Mn
Mar 31, 2022 686.76 Mn
Dec 31, 2021 513.78 Mn
Sep 30, 2021 518.18 Mn
Jun 30, 2021 212.44 Mn